EUVIMEDEUVIMED entdecken
Crossref

Using capillary electrophoresis sodium dodecyl sulfate (CE‐SDS) and liquid chromatograph mass spectrometry (LC–MS) to identify glycosylated heavy chain heterogeneity in the anti‐VEGFR‐2 monoclonal antibody

Meng Li, Xueyu Zhao, Gang Wu, Wenbo Wang, Jialiang Du, Gangling Xu, Maoqin Duan, Zhihao Fu, Chuanfei Yu, Lan Wang iD

ELECTROPHORESIS · 2024

DOI: 10.1002/elps.202300258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ELECTROPHORESIS, 2024. Verfasst von Meng Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biologi…. Hauptthemen laut MEDLINE: Electrophoresis, Capillary, Antibodies, Monoclonal, Mass Spectrometry, Vascular Endothelial Growth Factor Receptor-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Key Research and Development Program, Japan China Sasakawa Medical Fellowship, National Basic Research Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The size variant, which can be measured by capillary electrophoresis sodium dodecyl sulfate (CE‐SDS), is a critical quality attribute of monoclonal antibodies (mAbs). The CE‐SDS size heterogeneity can hardly be identified by tandem mass spectrometry, which is an intractable obstacle of mAb development and quality control across the industry. We analyzed the purity of an anti‐vascular endothelial growth factor receptor 2 (VEGFR‐2) mAb, an antagonist of the human VEGFR‐2, through reduced CE‐SDS and observed glycosylated heavy chain heterogeneity. The heterogeneity has potential impact on safety, efficacy, and stability of drugs for clinical use. Therefore, it should be characterized so as to evaluate its potential risk. In order to identify the heterogeneity, we used mass spectrometry to confirm that the molecular size heterogeneity was not due to peptide bond cleavage in the heavy chain. Subsequently, we employed mass‐spectrometry–glycosylation profiling and CE‐SDS analysis of various glycosidase‐treated samples, in addition to the preparation of mAb references with different glycoforms. Ultimately, we demonstrated that the heavy chain heterogeneity was induced by different levels of galactosylation modifications which will potentially impact the efficacy of antibody drugs (i.e., complement‐dependent cytotoxicity). In this study, potential risk caused by heavy chain size heterogeneity was evaluated, which addressed the obstacle of mAb development and quality control. Therefore, this study offers a feasible approach for the investigation and identification of heavy chain heterogeneity in reduced CE‐SDS, providing a novel strategy for mAb quality control and evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electrophoresis, CapillaryAntibodies, MonoclonalMass SpectrometryVascular Endothelial Growth Factor Receptor-2GlycosylationChromatography, LiquidHumansImmunoglobulin Heavy ChainsSodium Dodecyl SulfateAnimalsLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

capillary electrophoresis sodium dodecyl sulfateglycosylated heavy chainheterogeneityliquid chromatograph mass spectrometrysize variants

Substanzen

Antibodies, MonoclonalVascular Endothelial Growth Factor Receptor-2Immunoglobulin Heavy ChainsSodium Dodecyl Sulfate

Autor:innen und Institutionen

  • NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, National Institutes for Food and Drug Control, Beijing,…
  • Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing, P. R. China.

ORCID-Profile: Lan Wang

Förderung

  • National Key Research and Development Program
  • Japan China Sasakawa Medical Fellowship
  • National Basic Research Program of China

Zitieren

APA

Li, M., Zhao, X., Wu, G., Wang, W., Du, J., Xu, G., Duan, M., Fu, Z., Yu, C., & Wang, L. (2024). Using capillary electrophoresis sodium dodecyl sulfate (CE‐SDS) and liquid chromatograph mass spectrometry (LC–MS) to identify glycosylated heavy chain heterogeneity in the anti‐VEGFR‐2 monoclonal antibody. ELECTROPHORESIS. https://doi.org/10.1002/elps.202300258

Vancouver

Li M, Zhao X, Wu G, Wang W, Du J, Xu G, et al. Using capillary electrophoresis sodium dodecyl sulfate (CE‐SDS) and liquid chromatograph mass spectrometry (LC–MS) to identify glycosylated heavy chain heterogeneity in the anti‐VEGFR‐2 monoclonal antibody. ELECTROPHORESIS. 2024. doi:10.1002/elps.202300258

BibTeX
@article{Li2024,
  author = {Li, Meng and Zhao, Xueyu and Wu, Gang and Wang, Wenbo and Du, Jialiang and Xu, Gangling and Duan, Maoqin and Fu, Zhihao and Yu, Chuanfei and Wang, Lan},
  title = {Using capillary electrophoresis sodium dodecyl sulfate (CE‐SDS) and liquid chromatograph mass spectrometry (LC–MS) to identify glycosylated heavy chain heterogeneity in the anti‐VEGFR‐2 monoclonal antibody},
  journal = {ELECTROPHORESIS},
  year = {2024},
  doi = {10.1002/elps.202300258}
}
Kostenlos starten →